Cargando…
Therapeutics for the treatment of coronavirus disease 2019 in children and adolescents
Coronavirus disease 2019 (COVID-19) is a mild to moderate respiratory illness in most children and adolescents, but a small proportion develop severe or critical illness. Although pediatric clinical trials for the treatment of COVID-19 are sparse, there are some available drugs for children and adol...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Pediatric Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348956/ https://www.ncbi.nlm.nih.gov/pubmed/35760410 http://dx.doi.org/10.3345/cep.2022.00458 |